• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

42% layoffs announced in NVS global innovative meds

Quote




anonymous said:
Lol, let's not forget that the US sales force performance (or lack of it) has a big part to play in this whole saga ....whether you care or not!
Click to expand...


Spoken like a true home office fool who doesn’t understand sales or even the industry in the slightest. How many millions has Novartis spent on ridiculous selling models and training that is all worthless… as is 90% of the marketing research and strategies and then the STEM rides to evaluate which of their strategies sales reps aren’t executing so that they can do even more testing.
 




anonymous said:
Spoken like a true home office fool who doesn’t understand sales or even the industry in the slightest. How many millions has Novartis spent on ridiculous selling models and training that is all worthless… as is 90% of the marketing research and strategies and then the STEM rides to evaluate which of their strategies sales reps aren’t executing so that they can do even more testing.
Click to expand...

Exactly. Quite right. And still the reps don't get it right! Lol
 




Top Bottom
Back
Quote